LIVE — Last crawled: 2026-05-07 17:57 JST
Vol.1 — May 8, 2026
MSC Portal Regulatory Watch All Entries (128)
Standards, Guidance & Notices
Showing 81–90 of 128
EU
MDCG
MDCG 2022-15
Guidance on appropriate surveillance regarding the transitional provisions under Article 110 of the IVDR with regard to devices covered by certificates according to the IVDD
PUBLISHED NEW SaMD Classification
MDCG 2022-15 — Guidance on appropriate surveillance regarding the transitional provisions under Article 110 of the IVDR with regard to devices covered by certificates according to the IVDD — (September 2022)
Published: 2022-09-01
EU
MDCG
MDCG 2022-14
Transition to the MDR and IVDR - Notified body capacity and availability of medical devices and IVDs
PUBLISHED NEW AI / Machine Learning
MDCG 2022-14 — Transition to the MDR and IVDR - Notified body capacity and availability of medical devices and IVDs — (August 2022)
Published: 2022-08-01
EU
MDCG
MDCG 2022-12
Guidance on harmonised administrative practices and alternative technical solutions until Eudamed is fully functional (for Regulation (EU) 2017/746 on in vitro diagnostic medical devices)
PUBLISHED NEW SaMD Classification
MDCG 2022-12 — Guidance on harmonised administrative practices and alternative technical solutions until Eudamed is fully functional (for Regulation (EU) 2017/746 on in vitro diagnostic medical devices) — (July 2022)
Published: 2022-07-01
JFMDA
Notice
jaame-well-known-matters-gs1-128
Inquiry Contact Desk Establishment for GS1-128 Barcode Reading Application for Medical Devices
PUBLISHED NEW SaMD Classification
JAAME PMS Committee announcement (June 1, 2022) establishing inquiry procedures and publishing frequently asked questions regarding GS1-128 barcode reading applications for medical device identification and traceability purposes.
Published: 2022-06-01
CEN/
CENELEC
EN ISO 14971:2019/A11:2021
EN ISO 14971:2019/A11:2021 Medical devices – Application of risk management to medical devices
PUBLISHED NEW Risk Management
This harmonized standard under EU MDR prescribes systematic risk management processes that manufacturers must implement throughout the medical device lifecycle. The document specifies methodologies for hazard identification, risk analysis, risk evaluation, and implementation of risk control measures with verification and validation. Manufacturers should establish documented risk management files demonstrating that identified hazards have been adequately controlled and that residual risks are acceptable. The standard requires post-market surveillance planning to monitor device performance and identify emerging safety concerns. Risk management must be proportionate to the device's intended use and classification. This systematic approach serves as the foundational framework for ensuring both safety and effectiveness of medical devices. The amendment was published in the EU Official Journal via Decision 2022/757.
Published: 2022-05-11
EU
MDCG
MDCG 2022-8
Regulation (EU) 2017/746 - application of IVDR requirements to ‘legacy devices’ and to devices placed on the market prior to 26 May 2022 in accordance with Directive 98/79/EC
PUBLISHED NEW SaMD Classification
MDCG 2022-8 — Regulation (EU) 2017/746 - application of IVDR requirements to ‘legacy devices’ and to devices placed on the market prior to 26 May 2022 in accordance with Directive 98/79/EC — (May 2022)
Published: 2022-05-01
JFMDA
Notice
jaame_20220325_経産省ヘルスケア国際展開
METI Healthcare International Development Website Release
PUBLISHED NEW SaMD Classification
Announcement of METI Healthcare Industry Division's new web portal providing consolidated information on past support programs, research reports, and government agency consultation services for healthcare industry internationalization.
Published: 2022-03-25
JIS
Std
JIST623661
JIS T 62366-1:2022 Medical devices - Application of usability engineering to medical devices - Part 1: Design and evaluation (equivalent to IEC 62366-1:2015+Amd.1:2020)
PUBLISHED NEW Usability
This JIS standard specifies usability engineering processes for analyzing, specifying, developing, and evaluating safety-related human factors in medical devices, corresponding to IEC 62366-1:2015+Amendment 1:2020. The document establishes requirements for identifying and mitigating use errors that could result in harm to patients or operators, integrating human factors engineering into the device development lifecycle. Manufacturers must characterize the intended use environment, identify hazards associated with user interactions, develop mitigations through design and training, and conduct usability validation studies. The standard operates in conjunction with JIS T 14971 (risk management), as use-related risks must be identified and controlled through systematic usability engineering. The processes defined ensure that medical device designs accommodate user capabilities, limitations, and context of use to prevent foreseeable misuse. By systematically applying usability engineering principles, manufacturers reduce the likelihood of use errors and associated patient harm throughout the device lifecycle.
Published: 2022-03-25
JFMDA
Notice
jaame_20220314_承認審査講習会R3
Fiscal 2021 Collaborative Plan for Medical Device Regulation and Review Optimization: Marketing Approval Review Training Program
PUBLISHED NEW SaMD Classification
Video viewing platform for PMDA collaborative plan training program (FY2021) covering marketing approval review procedures, regulatory requirements, and best practices for medical device manufacturers and regulatory professionals.
Published: 2022-03-14
CEN/
CENELEC
EN ISO 13485:2016/A11:2021
EN ISO 13485:2016/A11:2021 Medical devices – Quality management systems – Requirements for regulatory purposes
PUBLISHED NEW Quality Management
This harmonized standard under EU MDR establishes comprehensive requirements for quality management systems in medical device manufacturing and distribution. Manufacturers should implement systematic quality procedures covering the entire device lifecycle, from design and development through production, installation, and post-market surveillance activities. The standard requires organizations to establish documented procedures, maintain traceability, implement change controls, and conduct management review to demonstrate regulatory compliance. Risk-based approaches must be applied to manufacturing processes, supplier management, and complaint handling. The requirements apply to all medical device manufacturers seeking CE marking in the European Union. This amendment incorporates multiple corrigenda and was published in the EU Official Journal via Decision 2022/6.
Published: 2022-01-04
1 7 8 9 10 11 13